Sellas Life Sciences Group Inc (NASDAQ:SLS)
| 1.25 Delayed Data As of 3:59pm ET |  +0.07 / +5.93%Today’s Change | 1.17 Today|||52-Week Range 7.37 | -47.03% Year-to-Date |
Latest SLS News | Press Releases
No recent news for Sellas Life Sciences Group Inc.
Today’s Trading
| Previous close | 1.18 |
| Today’s open | 1.20 |
| Day’s range | 1.20 - 1.27 |
| Volume | 11,610 |
| Average volume (3 months) | 352,063 |
| Market cap | $36.2M |
Data as of 3:59pm ET, 03/29/2023
Growth & Valuation
| Earnings growth (last year) | -59.27% |
| Earnings growth (this year) | +67.92% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -86.84% |
| P/E ratio | NM |
| Price/Sales | 45.77 |
| Price/Book | 5.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TXMDTherapeuticsMD Inc | 0.00 | 0.00% |
| ---- | ||
| NYMXNymox Pharmaceutical... | -0.06 | -15.03% |
| OCXOncoCyte Corp | +0.02 | +5.52% |
Data as of 3:59pm ET, 03/29/2023
Financials
| Next reporting date | May 17, 2023 |
| EPS forecast (this quarter) | -$0.29 |
| Annual revenue (last year) | $1.0M |
| Annual profit (last year) | -$41.3M |
| Net profit margin | -4,130.10% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
